Private Capital Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Private Capital Group’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,907	Closed	-$70	–	2249
2017 Q4	$70	Buy	+3,907	New	+$48.1K	0.02%	545

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Private Capital Group's SCMP Position: Q1 2018 in Review

Private Capital Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 3,907 shares — an estimated $70 sold.

Private Capital Group first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $70 in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Private Capital Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Private Capital Group sold 3,907 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $70.
Private Capital Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
Private Capital Group's Sucampo Pharmaceuticals, Inc. position peaked at $70 in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Private Capital Group's 13F filing for Q1 2018, filed 16 May 2018.